Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound.
Saved in:
| Title: | Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound. |
|---|---|
| Authors: | Spiers, Laura1,2,3 (AUTHOR), Gray, Michael3,4 (AUTHOR), Lyon, Paul2 (AUTHOR), Sivakumar, Shivan1,2 (AUTHOR), Bekkali, Noor2 (AUTHOR), Scott, Shaun5 (AUTHOR), Collins, Linda6 (AUTHOR), Carlisle, Robert4 (AUTHOR), Wu, Feng7 (AUTHOR), Middleton, Mark1 (AUTHOR), Coussios, Constantin4 (AUTHOR) laura.spiers@ouh.nhs.uk |
| Source: | BMC Cancer. 9/23/2023, Vol. 23 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
